PCN194 COST-EFFECTIVENESS ANALYSIS OF PEMBROLIZUMAB IN...

PCN194 COST-EFFECTIVENESS ANALYSIS OF PEMBROLIZUMAB IN COMBINATION WITH CARBOPLATIN AND PACLITAXEL FOR PREVIOUSLY UNTREATED PATIENTS WITH METASTATIC SQUAMOUS NON-SMALL CELL LUNG CANCER IN ENGLAND

Harding, T., Dawson, H., Insinga, R., Topaloudi, V., Ejzykowicz, F., Zhang, Y.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.390
Date:
November, 2019
File:
PDF, 381 KB
2019
Conversion to is in progress
Conversion to is failed